BriaCell (BCTX) Therapeutics presents positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters at the 2025 San Antonio Breast Cancer Symposium, SABCS, taking place December ...
Purple Biotech Ltd. announced significant progress in its clinical development pipeline during the AACR Annual Meeting 2025, providing updates on its therapies CM24 and NT219, and progressing toward ...
Xilio Therapeutics, a clinical-stage biotechnology company, announced progress on its pipeline and first-quarter financial results, highlighting initial Phase 2 data for vilastobart, a tumor-activated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback